openPR Logo
Press release

GABA Supplements Market to Reach US$ 71M by 2032, Driven by Rising Health & Wellness Trends

09-04-2025 03:18 PM CET | Food & Beverage

Press release from: Persistence Market Research

Overview of the Market

The global GABA (Gamma-Aminobutyric Acid) supplements market is witnessing steady growth as consumers increasingly seek natural solutions for stress relief, sleep improvement, and cognitive health. In 2025, the market was valued at US$ 48.5 million, reflecting rising consumer awareness about the benefits of GABA in supporting neurological balance and mental well-being. The market is projected to expand at a CAGR of 5.6%, reaching US$ 71.0 million by 2032, driven by increasing demand for dietary supplements that promote relaxation, mood regulation, and overall wellness.

Among product forms, capsules dominate the market, expected to generate the highest revenue over the forecast period. Capsules provide a convenient and accurate dosage option, which resonates with consumers who prefer easy-to-use formats over powders or liquids. Geographically, North America leads the market, supported by high consumer spending on health supplements, growing awareness of functional nutrition, and the presence of well-established supplement distribution channels. Europe and Asia-Pacific are also witnessing growth, spurred by increased health consciousness and rising adoption of nutraceuticals among younger demographics.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/33376

Key Highlights from the Report

Global GABA supplements market was valued at US$ 48.5 million in 2025.

The market is projected to reach US$ 71.0 million by 2032, at a CAGR of 5.6%.

Capsules segment is expected to be the highest revenue generator through 2032.

North America leads the market due to high consumer awareness and spending power.

Rising demand for stress-relief and sleep-enhancing supplements drives market growth.

Increasing availability of GABA supplements through online and offline channels supports expansion.

Market Segmentation

The global GABA supplements market is segmented by product type, end-user, and distribution channel. By product type, capsules dominate, followed by powders, tablets, and liquid formulations. Capsules are preferred due to ease of consumption, precise dosing, and better shelf-life stability. Powders appeal to consumers seeking customizable dosages or incorporation into shakes and beverages, while liquid formulations cater to users seeking rapid absorption.

By end-user, adults constitute the primary consumer group, driven by the need for stress management, sleep improvement, and cognitive support. Older adults also represent a growing segment, as GABA supplementation is increasingly associated with neurological health and mood stabilization. Children and adolescents are a smaller but emerging segment, primarily targeted through functional beverages enriched with GABA.

In terms of distribution, online channels are witnessing rapid growth, enabled by e-commerce platforms and direct-to-consumer subscription models. Offline retail, including pharmacies, health stores, and supermarkets, continues to contribute significantly, particularly in regions where consumers prefer in-person purchase and consultation.

Regional Insights

Regionally, North America dominates the GABA supplements market, fueled by high disposable income, robust healthcare infrastructure, and growing consumer inclination toward preventive healthcare. The U.S. represents the largest market within the region, with widespread awareness of dietary supplements and easy access to both domestic and international brands.

Europe is another key region, witnessing steady growth due to increasing consumer interest in natural remedies and nutraceutical products. Germany, the U.K., and France are major contributors, supported by strong retail networks and regulatory frameworks that facilitate supplement consumption. Asia-Pacific is emerging as a high-growth region, driven by rising urbanization, growing health-conscious middle-class populations, and increasing acceptance of Western nutraceutical products. Markets such as Japan, China, and India are showing significant adoption, supported by expanding online retail penetration and rising disposable incomes.

Market Drivers

The GABA supplements market is propelled by increasing consumer focus on mental health, stress management, and sleep quality. Rising prevalence of lifestyle-related disorders, such as anxiety and insomnia, has led to greater adoption of natural supplements as alternatives to pharmaceutical treatments. The growing awareness of nutraceutical benefits, combined with rising disposable income and convenient product forms like capsules and powders, further accelerates market growth. The proliferation of e-commerce platforms and direct-to-consumer sales models has also expanded market reach, providing easy access to a wide variety of GABA supplements.

Market Restraints

Despite growth prospects, the GABA supplements market faces certain challenges. Regulatory restrictions in some regions, including labeling requirements and health claim limitations, can hinder product introduction and marketing. Additionally, a lack of consumer awareness about optimal dosage, efficacy concerns, and skepticism regarding supplement quality may limit adoption. Competition from alternative natural and pharmaceutical remedies for stress and sleep management also acts as a restraint, challenging market players to differentiate their products through innovation and certification.

Market Opportunities

The GABA supplements market offers significant opportunities in product innovation, premium formulations, and emerging regional markets. There is growing potential in developing functional blends that combine GABA with other nutrients, vitamins, or adaptogens to enhance cognitive and mental health benefits. Expansion into Asia-Pacific and Latin American markets presents opportunities, driven by rising health consciousness and increasing online retail penetration. Partnerships with health professionals, wellness platforms, and subscription-based services can further accelerate market penetration. Technological innovations in formulation, including time-release capsules and chewable variants, provide additional avenues for growth.

Reasons to Buy the Report

Gain comprehensive insights into market size, growth forecasts, and emerging trends.

Understand consumer behavior and preferences driving GABA supplement adoption.

Analyze detailed market segmentation by product type, end-user, and distribution channel.

Evaluate regional market dynamics and potential opportunities for expansion.

Assess competitive landscape, strategies, and recent developments in the industry.

Frequently Asked Questions (FAQs)
How Big is the Market?
Who are the Key Players in the Global Market for GABA Supplements?
What is the Projected Growth Rate of the Market?
What is the Market Forecast for 2032?
Which Region is Estimated to Dominate the Industry through the Forecast Period?
Company Insights

Key players operating in the global GABA supplements market include:
• NutraBio Labs
• NOW Foods
• Source Naturals
• Jarrow Formulas
• Swanson Health Products
• Doctor's Best
• Life Extension
• Nutricost
• GNC Holdings
• Pure Encapsulations

Recent Developments:

In 2024, NOW Foods launched a new GABA capsule variant with enhanced absorption technology to improve efficacy.

In 2025, Jarrow Formulas introduced a GABA powder line targeting fitness enthusiasts and consumers seeking personalized dosage options.

Conclusion

The global GABA supplements market is poised for steady growth, driven by rising consumer demand for natural solutions to stress, anxiety, and sleep-related issues. With a market valuation expected to reach US$ 71.0 million by 2032, the sector demonstrates strong potential for innovation, product diversification, and expansion into emerging markets. While regulatory constraints and efficacy concerns remain challenges, the increasing adoption of online retail channels, growing health consciousness, and technological advancements in formulation position the GABA supplements market for sustainable long-term growth.

Read More Related Reports:
Almond Milk Market: https://www.persistencemarketresearch.com/market-research/almond-milk-market.asp

D Mannose Market: https://www.persistencemarketresearch.com/market-research/d-mannose-market.asp

Bone Broth Protein Market: https://www.persistencemarketresearch.com/market-research/bone-broth-protein-market.asp

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GABA Supplements Market to Reach US$ 71M by 2032, Driven by Rising Health & Wellness Trends here

News-ID: 4170428 • Views: …

More Releases from Persistence Market Research

Europe Homogeneous Precious Metal Catalysts Market to Surpass US$ 4.49 Bn by 2031 on Back of 19.1% CAGR Growth
Europe Homogeneous Precious Metal Catalysts Market to Surpass US$ 4.49 Bn by 203 …
➤ Overview of the Market According to the latest study by Persistence Market Research, the Europe homogeneous precious metal catalysts market is poised to expand from US$ 1,318.4 Mn in 2024 to US$ 4,498.2 Mn by 2031, registering an impressive CAGR of 19.1%. This robust growth trajectory is attributed to rising investments in specialty chemical synthesis, pharmaceutical intermediates, and advanced material research, where homogeneous catalysts offer superior efficiency and selectivity. Increasing…
Global Pneumatic Fenders Market Expected to Register 3.5% CAGR, Reaching USD 572.5 Million by 2031 | Persistence Market Research
Global Pneumatic Fenders Market Expected to Register 3.5% CAGR, Reaching USD 572 …
The global pneumatic fenders market is projected for steady growth, driven by rising maritime trade, port infrastructure development, and a growing emphasis on safety in ship operations. Valued at US$ 450.0 million in 2024, the market is expected to reach US$ 572.5 million by 2031, reflecting a CAGR of 3.5% over the forecast period. Historically, the market grew at a CAGR of 3.0% between 2018 and 2024, indicating a consistent…
U.S. Industrial Enzymes Market to Surpass US$ 2.1 Bn by 2031 with 3.5% CAGR - Persistence Market Research
U.S. Industrial Enzymes Market to Surpass US$ 2.1 Bn by 2031 with 3.5% CAGR - Pe …
➤ Overview of the Market The U.S. industrial enzymes market forms a cornerstone of the country's bioeconomy, supporting industries ranging from food processing to pharmaceuticals, animal feed, and biofuel production. Enzymes act as biological catalysts, accelerating chemical reactions under mild conditions while reducing energy and chemical usage. Growing environmental concerns and the demand for greener manufacturing processes are prompting industries to replace synthetic catalysts with eco-friendly enzyme solutions. Advancements in biotechnology,…
Increasing Automotive Repair and Maintenance Demand to Drive Frame Alignment Systems Market to USD 750.0 Million by 2031 | Persistence Market Research
Increasing Automotive Repair and Maintenance Demand to Drive Frame Alignment Sys …
The global frame alignment systems market is poised for robust growth, reflecting the automotive industry's increasing emphasis on vehicle safety and precision repair technologies. Valued at US$ 502.1 million in 2024, the market is projected to reach US$ 750.0 million by 2031, registering a CAGR of 5.9% during the forecast period. Historically, the market experienced a CAGR of 4.1% between 2018 and 2024, highlighting consistent expansion driven by automotive repair…

All 5 Releases


More Releases for GABA

GABA Receptor Agonist Market: Projected Growth at 6.3% CAGR Through 2033
The global gamma-aminobutyric acid (GABA) receptor agonist market was valued at approximately USD 1.3 billion in 2023 and is anticipated to reach USD 2.4 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033 The global GABA receptor agonist market represents a critical segment within the pharmaceutical industry, focusing on medications that enhance the activity of gamma-aminobutyric acid, the brain's primary inhibitory neurotransmitter. This market has experienced steady…
Europe Gamma-Aminobutyric Acid (GABA) Market Size |Regional Outlook - 2032
"Gamma-Aminobutyric Acid (GABA) Market Snapshot 2024-2032: The Gamma-Aminobutyric Acid (GABA) Market 2024 report delivers a comprehensive analysis of market dynamics, utilizing extensive secondary research to present actionable insights. The report provides a detailed overview of the current market landscape, including size, share, demand trends, and growth trajectories, while offering projections for future developments. It thoroughly examines the Global Gamma-Aminobutyric Acid (GABA) Market, focusing on strategic frameworks and assessing methodologies adopted by…
Global GABA Market Will Generate Record Revenue by 2028
All the information is compiled together with the help of primary and secondary research techniques. This GABA market study report is a range of comprehensive data based on the detailed investigation of the past, present and future market condition. Business entrepreneurs can mark up their dominance and existence in the market using this data. Challenges that are likely to be faced by the organizations are also compiled in it in…
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Research Report 20 …
Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market: Driven factors and Restrictions factors The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes…
GABA Receptor Antagonists Market: Facts, Figures and Analytical Insights 2021-20 …
The GABA Receptor Antagonists Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed…
Global GABA Market Share, Size, Trends, Opportunities, Analysis and Forecast 202 …
GLOBAL INFO RESEARCH has recently published a research report titled, [Global GABA Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025] assessing various factors impacting its trajectory. Analysts have used primary and secondary research methodologies to determine the path of the market. The data includes historic and forecast values for a well-rounded understanding. The global GABA market is expected to augment in the forecast period owing to various drivers and opportunities…